Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Platinum-doublet Chemotherapy in First-line (1L) Non-squamous Non-small-cell Lung Cancer (Nsq-NSCLC) with PD-L1-high Expression Using Real-world Data

doi:10.3971/j.issn.1000-8578.2023.22.1473

Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Platinum-doublet Chemotherapy in First-line (1L) Non-squamous Non-small-cell Lung Cancer (Nsq-NSCLC) with PD-L1-high Expression Using Real-world Data[J]. Cancer Research on Prevention and Treatment, 2023, 50(8): 820-829. DOI: 10.3971/j.issn.1000-8578.2023.22.1473

Citation:

Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Platinum-doublet Chemotherapy in First-line (1L) Non-squamous Non-small-cell Lung Cancer (Nsq-NSCLC) with PD-L1-high Expression Using Real-world Data[J]. Cancer Research on Prevention and Treatment, 2023, 50(8): 820-829. DOI: 10.3971/j.issn.1000-8578.2023.22.1473

Citation:

Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Platinum-doublet Chemotherapy in First-line (1L) Non-squamous Non-small-cell Lung Cancer (Nsq-NSCLC) with PD-L1-high Expression Using Real-world Data[J]. Cancer Research on Prevention and Treatment, 2023, 50(8): 820-829. DOI: 10.3971/j.issn.1000-8578.2023.22.1473

Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Platinum-doublet Chemotherapy in First-line (1L) Non-squamous Non-small-cell Lung Cancer (Nsq-NSCLC) with PD-L1-high Expression Using Real-world Data

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (10)

Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Platinum-doublet Chemotherapy in First-line (1L) Non-squamous Non-small-cell Lung Cancer (Nsq-NSCLC) with PD-L1-high Expression Using Real-world Data

Graphical Abstract

Catalog

Export File

Citation

Format

Content